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Abstract 
Background 
Older adult functional declines may be partly attributable to sarcopenia (the age-
related loss of skeletal muscle mass and function), and also age-related fat gains. The 
associations of lifestyle factors with skeletal muscle and body fat changes are unclear.  
 
Aim 
To investigate how measures of ambulatory activity, dietary nutrient intake, vitamin 
D, chronic disease and medication use, associate with changes in muscle mass, lower-limb 
function, falls risk and body fat in community-dwelling older adults. 
 
Materials and Methods  
 Total N = 875 adults aged 50 - 80 years (51% female; mean age = 62 ± 7 years) 
participated at baseline and 2.6 ± 0.4 years later. Appendicular lean mass (ALM), leg lean 
mass, and body fat were assessed by Dual-energy X-ray Absorptiometry (DXA). Lower-limb 
muscle function was assessed by dynamometry, and leg and whole body muscle quality 
(LMQ and WBMQ) was calculated. Falls risk score was assessed by a Physiological Profile 
Assessment (PPA). Study factors including ambulatory activity (AA) measured by 
pedometer, 25-hydroxyvitamin D (25OHD) by radioimmunoassay, radiographic osteoarthritis 
(ROA) by X-ray, and dietary nutrient intake, pain, and statin medication use reported by 
questionnaire, were assessed. 
 
Results 
 Total body and trunk fat mass were negatively associated with seasonally-adjusted 
pedometer-determined AA in both men and women in cross-sectional analyses, but men only 
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in prospective analyses. In women only, significant positive associations for leg strength and 
LMQ, and also WBMQ, with AA were observed. Energy-adjusted protein, iron, magnesium, 
phosphorus, and zinc intakes were significant positive predictors of change in ALM, while 
retinol was a negative predictor of change in ALM. Nutrient intakes did not predict changes 
in knee extension strength. 25OHD positively predicted change in leg strength and LMQ, and 
change in 25OHD was also predicted by baseline percentage ALM (%ALM), leg strength, 
LMQ and AA, after adjustment for sun exposure and body fat. Knee and hip pain measures 
predicted deleterious changes in muscle function and falls risk in women only; no muscle 
function associations were observed for ROA in either sex. Over time, statin users 
demonstrated decreased leg strength and LMQ, and increased falls risk, compared to non-
users. 
 
Conclusions 
This series of related analyses of a prospective population-based study of community-
dwelling older adults provides considerable insight into the epidemiology of sarcopenia. 
Interventions focused on maintaining or improving behaviours including physical activity, 
diet, and sun exposure, as well as more effective management of chronic disease, may be 
efficacious in the prevention of skeletal muscle mass loss, functional decline, and obesity.
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